X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2956) 2956
Book Review (1143) 1143
Publication (231) 231
Book Chapter (13) 13
Conference Proceeding (8) 8
Dissertation (1) 1
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cooperative-oncology-group (2754) 2754
index medicus (2523) 2523
humans (2482) 2482
oncology (2042) 2042
female (1273) 1273
male (1140) 1140
middle aged (1117) 1117
aged (1116) 1116
chemotherapy (1095) 1095
antineoplastic combined chemotherapy protocols - therapeutic use (1029) 1029
adult (842) 842
cancer (761) 761
treatment outcome (697) 697
phase-ii trial (557) 557
cisplatin (497) 497
phase-iii trial (485) 485
antineoplastic agents - therapeutic use (458) 458
aged, 80 and over (434) 434
prognosis (429) 429
lung neoplasms - drug therapy (417) 417
care and treatment (407) 407
gemcitabine (399) 399
neoplasm staging (393) 393
antineoplastic combined chemotherapy protocols - adverse effects (378) 378
deoxycytidine - analogs & derivatives (360) 360
paclitaxel (353) 353
survival rate (352) 352
survival analysis (351) 351
combined modality therapy (343) 343
survival (326) 326
trial (297) 297
carcinoma, non-small-cell lung - drug therapy (296) 296
disease-free survival (296) 296
hematology (296) 296
randomized-trial (286) 286
research (283) 283
cisplatin - administration & dosage (281) 281
clinical trials as topic (275) 275
colony-stimulating factor (271) 271
carcinoma (268) 268
deoxycytidine - administration & dosage (266) 266
therapy (262) 262
pharmacology & pharmacy (258) 258
radiotherapy (246) 246
hematology, oncology and palliative medicine (245) 245
combination chemotherapy (241) 241
paclitaxel - administration & dosage (241) 241
pancreatic cancer (241) 241
melanoma (239) 239
combination (238) 238
abridged index medicus (227) 227
neoplasm metastasis (226) 226
drug administration schedule (225) 225
randomized controlled trials as topic (222) 222
carboplatin (220) 220
quality-of-life (219) 219
pancreatic neoplasms - drug therapy (218) 218
randomized trial (217) 217
phase-ii (215) 215
surgery (215) 215
metastasis (213) 213
retrospective studies (211) 211
lung neoplasms - pathology (206) 206
drug therapy (202) 202
radiation-therapy (201) 201
chemotherapy, adjuvant (196) 196
clinical trials (188) 188
medicine & public health (187) 187
health aspects (186) 186
cell lung-cancer (182) 182
melanoma - drug therapy (175) 175
antineoplastic combined chemotherapy protocols - administration & dosage (171) 171
pancreatic neoplasms - pathology (170) 170
risk factors (166) 166
docetaxel (165) 165
respiratory system (164) 164
breast neoplasms - drug therapy (160) 160
carboplatin - administration & dosage (157) 157
quality of life (155) 155
adenocarcinoma (152) 152
doxorubicin (148) 148
fluorouracil - administration & dosage (148) 148
follow-up studies (147) 147
immunotherapy (146) 146
5-fluorouracil (141) 141
medicine, general & internal (141) 141
dose-response relationship, drug (138) 138
disease progression (137) 137
toxicity (135) 135
1st-line treatment (132) 132
antineoplastic agents (132) 132
etoposide (132) 132
lung neoplasms - mortality (132) 132
fluorouracil (131) 131
carcinoma, non-small-cell lung - pathology (130) 130
urinary bladder neoplasms - drug therapy (130) 130
antineoplastic agents - administration & dosage (129) 129
lung cancer (128) 128
adjuvant therapy (127) 127
analysis (127) 127
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2888) 2888
French (44) 44
German (25) 25
Polish (5) 5
Spanish (5) 5
Italian (1) 1
Japanese (1) 1
Lithuanian (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2017, Volume 35, Issue 5, pp. 490 - 490
Purpose Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is treatment-responsive. Definitive chemoradiation results in high... 
ORGAN PRESERVATION | THERAPY | PLUS CETUXIMAB | CISPLATIN | ONCOLOGY | LOCALLY-ADVANCED HEAD | STANDARD FRACTIONATION | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | NECK-CANCER | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 8, pp. 707 - 714
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 224 - 233
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 04/2016, Volume 14, Issue 4, pp. 450 - 450
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma focuses on adjuvant therapy and treatment of in-transit... 
HIGH-RISK MELANOMA | BACILLUS-CALMETTE-GUERIN | SENTINEL LYMPH-NODE | STAGE-III MELANOMA | ONCOLOGY | CARBON-DIOXIDE LASER | CUTANEOUS METASTATIC MELANOMA | HIGH-DOSE INTERFERON-ALPHA-2B | IN-TRANSIT MELANOMA | ISOLATED LIMB PERFUSION | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 26, pp. 2517 - 2526
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2011, Volume 364, Issue 19, pp. 1817 - 1825
In this study, a four-drug combination chemotherapy regimen was associated with objective responses in more than 30% of patients and increased survival by more... 
PHASE-III TRIAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | SOLID TUMORS | CLINICAL-TRIALS | IRINOTECAN | OXALIPLATIN | 1ST-LINE THERAPY | COMBINATION | CARCINOMA | COOPERATIVE-ONCOLOGY-GROUP | Leucovorin - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Severity of Illness Index | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Quality of Life | Aged | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Chemotherapy, Combination | Usage | Care and treatment | Gemcitabine | Pancreatic cancer | Leucovorin | Comparative analysis | Drug therapy | Fluorouracil | Clinical trials | Cytotoxicity | Pancreas | Patients | Index Medicus | Abridged Index Medicus
Journal Article